University of Physical Education in Poznan
Poznan, Poland
NCT Number: NCT06486623
The study included 8-weeks supplementation of black chokeberry extract with 18% standardization of the anthocyanins content (dose 2×200 mg per day), or a placebo product that was made from chokeberry fiber.
Purpose:
The aim of the study is effectiveness check of black chokeberry intake as a potential factor which, due to its ability to reduce inflammation and chelate iron ions, will have an impact on minimizing undesirable changes in the red blood cell system.
Hypothesis:
Main hypothesis: Supplementation of black chokeberry (Aronia melanocarpa) has a positive effect on iron economy of female swimmers.
Auxiliary hypotheses:
1. Supplementation of black chokeberry enhances the antioxidant status and has a positive effect on the prooxidant-antioxidant balance. 2. Supplementation of black chokeberry reduce inflammation induced by intensive exercises, by reducing inflammatory markers.
Study plan:
Before first term of the study:
Control of Menstrual Cycle Phases since March 2023 (installing the application on the phone - Menstrual Period Tracker calendar).
First term of the study:
1. Menstrual cycle control survey. 2. Conduct a body composition analysis. 3. Collection of blood samples before the exercise test for biochemical determinations. 4. Exercise test in the swimming pool - crawl style intensive test (800 m + 200 m + 50 m). 5. Collection of blood immediately after exercise and 3 hours later. 6. Supplementation for nearly 56 days, depending on the length of the menstrual cycle.
Second term of the study:
Repeat the measurements from the 1st date of test.
Participants: The group of selective and homogeneous female swimmers, who train swimming intensively and attend the Sports Championship School Complex.
Looking for future studies?
Notify Me12 year–19 year
Female
Interventional
Phase 1 / Phase 2
Poznan, Poland
This study included 8-weeks supplementation of black chokeberry extract with 18% standardization of the anthocyanins content (dose 2×200 mg per day), or a placebo product that was made from chokeberry fiber. The first date of research completed the group of twenty-four and homogeneous female swimmers, who train swimming intensively and attend the Sports Championship School Complex. The second date of research completed the group of twenty-two selective and homogeneous female swimmers, who train swimming intensively and attend the Sports Championship School Complex.
Purpose:
The aim of the study is effectiveness check of black chokeberry intake as a potential factor which, due to its ability to reduce inflammation and chelate iron ions, will have an impact on minimizing undesirable changes in the red blood cell system.
Hypothesis:
Main hypothesis: Supplementation of black chokeberry (Aronia melanocarpa) has a positive effect on iron economy of female swimmers.
Auxiliary hypotheses:
The research is going to be carried out as a medicinal experiment with tissue interference (approval of Research Ethics Committee: 538/22 of 06/23/2022, with changes: 221/23 of 03/09/2023). All swimmers qualified to study based on inclusion and exclusion criteria and were informed of the extract course of the study and gave written consent to participate.
EXPERIMENTAL PROCEDURE, WHICH WAS APPLIED (STUDY PLAN):
A. Before first term of the study:
Control of Menstrual Cycle Phases since March 2023 (installing the application on the phone - Menstrual Period Tracker calendar) and three surveys in three terms.
B. First term of the study:
Blood samples were collected from the elbow vein into two 4-ml tubes (to obtain serum) and centrifuged at 3,000 rpn and into 2,7-ml tubes to determine morphology. Morphology was determined on the same day the samples were collected, while serum was frozen and stored at -80 Celsius degrees until assays were performed. In addition, before and immediately after the exercise test, capillary blood was drawn from the earlobe to determine lactate levels.
Lactate level were determined immediately after capillary blood sampling using a commercial available kit (Dr Lange, Germany). The concentration of lactate was determined in mmol/l. Other measurements were determined using ELISA kits (DRG Medtek).
C. Second term of the study:
Blood samples were collected from the elbow vein into two 4-ml tubes (to obtain serum) and centrifuged at 3,000 rpn and into 2,7-ml tubes to determine morphology. Morphology wa determined on the same day the samples were collected, while serum was frozen and stored at -80 Celsius degrees until assays were performed. In addition, before and immediately after the exercise test, capillary blood was drawn from the earlobe to determine lactate levels.
Lactate level were determined immediately after capillary blood sampling using a commercial available kit (Dr Lange, Germany). The concentration of lactate was determined in mmol/l. Other measurements were determined using ELISA kits (DRG Medtek).
Data collection, analysis in laboratory, statistical analysis and preparation articles to publication.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Supplement group: supplement of diet - black chokeberry extract (capsules) with 18% standardization of the anthocyanins content (one capsule contained 200 mg). Each capsule also contained: chokeberry fiber, E460b magnesium salts of stearic acid (anti-caking agent), E551 silicon dioxide (anti-caking agent), hydrocypropyl methylcellulose (capsule shell) and E171 titanium dioxide (shell colour).
The producer of all capsules is MLD Biotrade in Poznan.
Other names: Aronia melanocarpa
Placebo group: placebo product - chokeberry fiber (placebo capsules, which were made from chokeberry fiber).
The producer of all capsules is MLD Biotrade in Poznan.
Other names: Placebo product
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
erythrocytes: RBC [10^6/mL], HGB [g/dL], HCT [%], MCV [mm^3], MCH [pg], MCHC [g/dL], RDW [%],
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
leukocytes: WBC [10^3/mL], LYM [10^3/mL], MON [10^3/mL], GRA [10^3/mL], LYM [%], MON [%], GRA [%],
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
thrombocytes: PLT [10^3/mL], MPV [mm^3], PCT [%], PDW [%]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
iron [µg/dl]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
hepcidin [ng/ml]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
transferrin [mg/ml]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
total iron-binding capacity (TIBC) [µg/dl]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
ferritin [ng/ml]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
erythroferrone [ng/mL]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
total antioxidant capacity [mmol/l]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
interleukin 6 [ng/L]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
interleukin 2 [ng/L]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
interleukin 10 [ng/L]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
C-reactive protein [mg/dL]
Time frame: At each exercise test (up to 15 minute before exercise)
progesterone [ng/ml]
Time frame: At each exercise test (up to 15 minute before exercise)
estradiol [pg/ml]
Time frame: At each exercise test (up to 15 minute before exercise)
luteinizing hormone (LH) [mIU/ml]
Time frame: At each exercise test (up to 15 minute before exercise)
follicle-stimulating hormone (FSH) [mIU/ml]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
myoglobin [ng/ml]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
hypoxanthine [mmol/l]
Time frame: At each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
lactic acid [mmol/l]
Time frame: Calculated with blood samples at each exercise test (up to 15 minute before exercise, up to 1 minute post exercise, 3 hours after)
unsaturated iron-binding capacity (UIBC)
Poznan University of Physical Education
Other
Effect of Supplementation With Anthocyanins Contained in Black Chokeberry (Aronia Melanocarpa) on Selected Indicators of Iron Metabolism in Female Swimmers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07186205
Anemia, Hematologic Diseases
Abidjan, Côte d’Ivoire
View Trial DetailsNCT06238895
Anemia, Anemia, Hypochromic
Lucerne, Switzerland
View Trial DetailsNCT06309641
Anemia, Hematologic Diseases
Falun, Sweden
View Trial DetailsNCT06251427
Iron Deficiencies, Iron Metabolism Disorders
Wageningen, Netherlands
View Trial Details